 |
|
|
 |
Reducing Depression In Cancer Patients Does Not Reduce Fatigue
Cancer patients often experience both depression and fatigue, and physicians have had good reason to think that relieving depression might also reduce fatigue. But a new large randomized trial has disproved that theory and shifted researchers' attention to other possible strategies to fight cancer-related fatigue. more
|
|
Chemotherapy And Radiation Together May Help Save Voicebox
People with cancer of the larynx often face laryngectomy -- surgery to remove the voicebox -- to help stop the spread of the cancer. Now, a new study shows that giving chemotherapy and radiation therapy together can put off the need for a laryngectomy and preserve use of the voicebox longer than the currently established practice of giving chemotherapy followed by radiation. more
|
|
|
|
Two Drugs May Block Spread Of Bone Metastases In Prostate Cancer
When prostate cancer spreads, it often invades the bones where it causes severe, debilitating pain. Two drugs currently under study may slow down this progression of the disease and improve quality of life, according to studies presented on 15 May 2001 at the annual meeting of the American Society of Clinical Oncology in San Francisco. more
|
|
Death Rate In Colon Cancer Patients Receiving Camptosar Sparks Concern
Patients taking a commonly prescribed treatment for colon cancer, Camptosar, died at almost three times the rate of patients who took other drugs for the same disease, said a biostatistician for the Mayo Clinic Thursday. more
|
|
Long-Chain Alcohol Found To Block Mechanism Of Fetal Alcohol Syndrome
An article in today’s "Federation of American Societies for Experimental Biology (FASEB) Journal" (Chen, S; Wilkemeyer, M; Sulik, K; and Charness, M. Octanol antagonism of ethanol teratogenesis, FASEB J. Volume 15, Number 9, July 2001) reports that the long-chain alcohol 1-octanol successfully blocks a mechanism leading to fetal alcohol syndrome (FAS). Viewed as paradoxical because it is the short-chain alcohol ethanol (beverage alcohol) that causes FAS, today’s finding nevertheless suggests a strategy for developing pharmaceutical interventions to prevent alcohol-related birth defects. more
|
|
|
